Effects of 6-month treatment with the glucagon like peptide-1 analogue liraglutide on arterial stiffness, left ventricular myocardial deformation and oxidative stress in subjects with newly diagnosed type 2 diabetes

BACKGROUND: Incretin-based therapies are used in the treatment of type 2 diabetes mellitus (T2DM) and obesity. We investigated the changes in arterial stiffness and left ventricular (LV) myocardial deformation after 6-month treatment with the GLP-1 analogue liraglutide in subjects with newly diagnos...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cardiovasc Diabetol
Auteurs principaux: Lambadiari, Vaia, Pavlidis, George, Kousathana, Foteini, Varoudi, Maria, Vlastos, Dimitrios, Maratou, Eirini, Georgiou, Dimitrios, Andreadou, Ioanna, Parissis, John, Triantafyllidi, Helen, Lekakis, John, Iliodromitis, Efstathios, Dimitriadis, George, Ikonomidis, Ignatios
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2018
Sujets:
Original Investigation
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5759220/
https://ncbi.nlm.nih.gov/pubmed/29310645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0646-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires